Key facts
- RockStep Solutions’s last known valuation is $35.3M (Aug 2022).
- It has raised $13.4M across 4 recorded rounds; the latest was Seed Round ($2.0M) in Nov 2023.
- RockStep Solutions has filed 6 Form Ds with the SEC since 2016, most recently Jan 2025 ($1.3M sold to 8 investors).
- Status: Acquired/Merged (Operating Subsidiary).
- ·Post-money valuations for all 4 rounds
- ·Watchlist + deal alerts for RockStep Solutions
Funding rounds
4 roundsAbout RockStep Solutions
Developer of laboratory-management software designed to offer in vivo study management for biotechnology, pharmaceutical, and academic sectors. The company's software focuses on managing researchers' data and operations, as well as offering data assurance, access control, and security, enabling users to track laboratory data in the cloud, improve collaboration, and launch their products easily.
- Sector
- Healthcare
- HQ
- Portland, ME, United States
- Founded
- 2013
- Employees
- 30
- Website
- rockstepsolutions.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
RockStep Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RockStep Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RockStep Solutions in its N-PORT filings yet. We sweep new filings monthly.